Literature DB >> 32856341

Systemic factors that shape cutaneous pathological scarring.

Chenyu Huang1, Rei Ogawa2.   

Abstract

Cutaneous pathological scars are fibrotic lesions that grow continuously, invade the adjacent skin, and are erythematous, itchy, and painful. Their etiology remains unclear but may involve genetic, local mechanical, and systemic factors. Here, we will summarize the main systemic factors that shape cutaneous pathological scarring, especially keloid formation and aggravation. They include circulating cytokines, chemokines, growth factors, particular cell types, sex hormones, the systemic renin-angiotensin system, and vitamin D, all of which directly shape the angiogenesis, inflammation, fibrosis, and remodeling in pathological scars. There are also several environmental factors that more indirectly influence pathological scar formation or progression, namely diet, smoking, psychological stress, and exercise. Notably, much of the evidence on these systemic factors focus on their effects on one pathological scar characteristic, namely their fibrosis. However, systemic factors probably also shape other pathological scar characteristics. We describe two new avenues of keloid research that may greatly improve our understanding of pathological scarring and the systemic factors that affect it. One is the multiple similarities between keloids and tumors; the other is the different stem-cell populations in keloids. We expect this research will greatly aid the development of diagnostic biomarkers for cutaneous pathological scars and drugs/techniques/regimens that prevent, improve, or cure these scars.
© 2020 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  diet preference; keloids; lifestyle profile; molecular circulating changes

Year:  2020        PMID: 32856341     DOI: 10.1096/fj.202001157R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

Review 1.  Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis.

Authors:  Chenyu Huang; Rei Ogawa
Journal:  Int J Mol Sci       Date:  2022-06-19       Impact factor: 6.208

2.  Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring.

Authors:  Chaoyu Zhang; Ting Wang; Li Zhang; Penghong Chen; Shijie Tang; Aizhen Chen; Ming Li; Guohao Peng; Hangqi Gao; Haiyan Weng; Haoruo Zhang; Shirong Li; Jinghua Chen; Liangwan Chen; Xiaosong Chen
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

3.  HOXA5 counteracts the function of pathological scar-derived fibroblasts by partially activating p53 signaling.

Authors:  Yimin Liang; Renpeng Zhou; Xiujun Fu; Chen Wang; Danru Wang
Journal:  Cell Death Dis       Date:  2021-01-05       Impact factor: 8.469

4.  Role of Skin Stretch on Local Vascular Permeability in Murine and Cell Culture Models.

Authors:  Tuna Demir; Hiroya Takada; Kishio Furuya; Masahiro Sokabe; Rei Ogawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-01-27

5.  Exosome Derived from Mesenchymal Stem Cells Alleviates Pathological Scars by Inhibiting the Proliferation, Migration and Protein Expression of Fibroblasts via Delivering miR-138-5p to Target SIRT1.

Authors:  Wen Zhao; Rui Zhang; Chengyu Zang; Linfeng Zhang; Ran Zhao; Qiuchen Li; Zhanjie Yang; Zhang Feng; Wei Zhang; Rongtao Cui
Journal:  Int J Nanomedicine       Date:  2022-09-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.